
Saturday, April 05, 2025 9:57:21 AM
Your hope resides on PHILIP leaving the MB??
Sad Man - KARMA..
_____________________________
exwannabe
Re: beartrap12 post# 759107
Friday, April 04, 2025 6:14:45 PM
Post#
759111
of 759162
Hang in there, Flipper. We are close, very close.
Damn, that sounds like the guy in the movie talking to the severely wounded loved one to hold on until they get medical help.
Flip is talking about leaving a message board is all. In reality, probably would be best for most all of us smile
Recent CVM News
- CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market • Business Wire • 04/23/2025 12:30:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:15:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:10:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (Canada) • 04/14/2025 02:10:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2025 05:00:21 PM
- New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses • Business Wire • 04/08/2025 01:51:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:51:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:49:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:46:47 PM
- CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients • Business Wire • 03/24/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 09:07:52 PM
- CEL-SCI Announces Closing of $2.5 Million Offering • Business Wire • 03/18/2025 08:05:00 PM
- CEL-SCI Announces Pricing of $2.5 Million Offering • Business Wire • 03/17/2025 07:24:00 PM
- CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine • Business Wire • 03/17/2025 12:00:00 PM
- CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial • Business Wire • 02/20/2025 01:00:00 PM
- CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks • Business Wire • 02/18/2025 01:30:00 PM
- CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer • Business Wire • 01/14/2025 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/13/2025 09:16:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 07:25:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 07:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 07:12:41 PM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM